|1.||Zhang, Xuan: 3 articles (02/2015 - 06/2011)|
|2.||Zhang, Qiang: 3 articles (02/2015 - 06/2011)|
|3.||Sitharaman, Balaji: 3 articles (01/2015 - 01/2013)|
|4.||Lu, Weiyue: 3 articles (10/2014 - 05/2009)|
|5.||Xie, Cao: 3 articles (10/2014 - 05/2009)|
|6.||Tan, Chalet: 3 articles (04/2014 - 06/2010)|
|7.||Katragadda, Usha: 3 articles (04/2014 - 06/2010)|
|8.||Teng, Quincy: 3 articles (04/2014 - 06/2010)|
|9.||Dai, Wenbing: 2 articles (02/2015 - 01/2015)|
|10.||Wang, Xueqing: 2 articles (02/2015 - 01/2015)|
|1.||Ovarian Neoplasms (Ovarian Cancer)
10/31/2011 - "Paclitaxel/17-AAG-loaded PEG-DSPE/TPGS mixed micelles were as effective in blocking the proliferation of human ovarian cancer SKOV-3 cells as the combined free drugs. "
06/15/2010 - "Cytotoxicity of 17-AAG formulated in PEG-DSPE/TPGS mixed micelles against human ovarian cancer SKOV-3 cells was comparable to that of free 17-AAG. "
10/06/2014 - "The inclusion of GE11-PEG-DSPE and PEG-DSPE at 2% and 4% mol ratios in the liposome formulation mediated a rapid accumulation of liposomes within 1 h after IV injection in the tumor tissues surrounding neovascular structures. "
01/16/2013 - "D-SP5-conjugated PEG-DSPE micelles displayed enhanced tumor homing (evidenced by near-infrared in vivo imaging). "
11/01/1999 - "The tumor-accumulation efficiency (AUC(Tumor)/AUC(Plasma)) of liposomal doxorubicin without PEG was 0.87, and this was more than twice that of the liposomal doxorubicin with 6% PEG-DSPE (0.31). "
11/01/1999 - "The 72-h tumor AUC was 1.44 times that of liposomal doxorubicin with 6% PEG-DSPE. "
03/01/1999 - "FA-PEG-DSPE significantly enhanced liposome binding to tumor cells. "
|4.||Breast Neoplasms (Breast Cancer)
01/01/2013 - "In this study, we report the cytotoxicity screening of O-GNRs water-solubilized with PEG-DSPE (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)]), using six different assays, in four representative cell lines; Henrietta Lacks cells (HeLa) derived from cervical cancer tissue, National Institute of Health 3T3 mouse fibroblast cells (NIH-3T3), Sloan Kettering breast cancer cells (SKBR3) and Michigan cancer foundation-7 breast cancer cells (MCF7). "
05/01/2000 - "Liposomes containing 0.5 or 1.0 mol% biotin-PEG-DSPE were compared in rats with a Staphylococcus aureus infection in the left calf muscle. "
03/01/1995 - "Although PG-PC-chol or PEG-DSPE-DSPE-chol liposomes encapsulating streptomycin were not bactericidal in the lungs, they reduced the level of MAC infection by more than 3 orders of magnitude compared with the level of MAC infection in untreated controls."
03/01/1995 - "Two liposome types with prolonged circulation (polyethyleneglycol-distearoylphosphatidylethanolamine [PEG-DSPE]-distearoylphosphatidylcholine [DSPC]-cholesterol [chol] or phosphatidylinositol [PI]-DSPC-chol) and conventional liposomes (phosphatidylglycerol [PG]-phosphatidylcholine [PC]-chol) encapsulating streptomycin and administered twice weekly were bactericidal to MAC strain 101 in the spleen when the level of infection after treatment was compared with the level of infection before treatment. "
|3.||alpha-tocopheryl polyethylene glycol succinate
|4.||Polyethylene Glycols (Polyethylene Glycol)
|8.||Folic Acid (Vitamin M)
|9.||Ethylene Glycol (Monoethylene Glycol)